Ascochlorin overcomes chemoresistance and regulates the plasticity of doxorubicin induced EMT via modulation of the NF-кB pathway in hepatocellular carcinoma

OBJECTIVE Doxorubicin-based therapy has been found to be not significantly effective for the treatment of advanced stage hepatocellular carcinomas(HCCs),which often undergo epithelial-mesenchymal transition(EMT)during tumor progression.Increasing evidence suggest(s)that epithelial cell transformation to mesenchymal state canenhance the ability to self-renew and confer greater resistance to the conventional chemotherapeutic drugs.The aim of this study was to examine the potential efficacyof ascochlorin,an isoprenoid antibiotic to overcome drug resistance induced by doxorubicin in HCC cell lines and to elucidate its underlying mechanism(s)of action.METHODS The effect of doxorubicin and ascochlorin on HCC cell lines was determined by MTT,Western blotting,immunofluorescence and NF-кB DNA binding assays.RESULTS Our results indicate that HCC cells that show a mesenchymal-like phenotype,are resistance to the doxorubicin therapy which directly correlated with an increased slug expression.We also observed that activation of NF-кB pathway plays an essential role in doxorubicin induced-chemoresistance and pharmacological inhibition of this pathway with ascochlorin can significantly reverse drug-induced invasion/migration and resistance in HCC cells.CONCLUSION Our results indicate that combination treatment of doxorubicin with ascochlorin has the potential to inhibit HCC growth and metastasis.

壳二孢氯素产生菌的鉴定及发酵培养基优化

目的对壳二孢氯素产生菌F05Z0761进行菌种鉴定,并进行培养基优化,提高其发酵单位。方法首先通过形态学特征进行鉴定,然后通过发酵培养基筛选实验并采用Plackett-Burman实验、最陡爬坡实验、中心组合实验设计等方法提高发酵单位。结果 F05Z0761经形态学鉴定显示该菌株属于镰刀菌属(Fusarium),并得到了优化后的发酵培养基配方即:淀粉1.8%、葡萄糖2.5%、棉籽粉1.9%、热榨黄豆饼粉0.8%和KH_2PO_40.2%,发酵单位较对照提高了4.38倍。结论由镰刀菌属产生壳二孢氯素在国内还未见报道,并将响应面实验设计应用于该菌株的发酵培养基优化中。

Cylindrocarpon olidum W1菌株代谢物中壳二孢氯素及其类似物的分离及抑菌活性

采用硅胶柱层析及高效液相色谱等技术从冬青卫矛内生真菌Cylindrocarpon olidum W1次生代谢物中分离鉴定出8个抑菌活性化合物W1-1~W1-8。经核磁共振氢谱和碳谱、高分辨质谱等技术,并结合相关文献确认其为壳二孢氯素及其类似物,分别为Ilicicolin A(W1-1)、5-Chlorocolletorin B(W1-2)、Ilicicolin B(W1-3)、Deacetylchloronectrin(W1-4)、Ilicicolin C(W1-5)、壳二孢氯素(W1-6)、Cylindrol A_4(W1-7)和Cylindrol B(W1-8)。抑菌活性测定结果表明:壳二孢氯素及其类似物对烟草青枯病菌有较强的抑制作用,上述化合物的最小抑制浓度分别为6.2 5、3.1 3、>1 0 0、3.1 3、6.2 5、1 2.5、2 5和2 5μg/m L;化合物W 1-2、W1-4和W1-5对番茄灰霉病菌和油菜菌核病菌菌丝生长亦有较强的抑制作用,其中对番茄灰霉病菌的抑制中浓度(IC_(50))分别为36.45、21.60和26.69μg/m L,对油菜菌核病菌的抑制中浓度分别为20.21、16.79和12.11μg/m L。

微生物来源的二氢乳清酸脱氢酶抑制剂F01WB-1315A,B

【目的】从微生物次生代谢产物中筛选免疫相关疾病治疗药物重要靶点——二氢乳清酸脱氢酶的抑制剂。【方法】利用自建的快速、高效的二氢乳清酸脱氢酶抑制剂的高通量筛选方法,从4560株真菌菌株中筛选阳性菌株。阳性菌株的发酵产物进行分离纯化获得活性化合物,再通过对活性化合物的紫外、质谱、核磁等理化数据的分析进行结构鉴定。【结果】筛选分离得到2个活性化合物F01WB-1315A和F01WB-1315B。F01WB-1315A对二氢乳清酸脱氢酶有强的抑制活性,IC50=0.07μg/mL,于20μg/mL浓度下对体外经ConA刺激活化的脾淋巴细胞增殖只有31.62%的抑制作用。F01WB-1315B对二氢乳清酸脱氢酶也有较强的抑制活性,IC50=0.51μg/mL,并且在20μg/mL浓度下对体外经ConA刺激活化的脾淋巴细胞增殖有98.12%的抑制作用。经过结构解析确定F01WB-1315A与壳二孢呋喃酮(Ascofuranone)结构相同,F01WB-1315B与壳二孢氯素(Ascochlorin)结构相同。【结论】F01WB-1315A和B在分子水平和细胞水平均表现出很好的免疫抑制活性,它们对二氢乳清酸脱氢酶的抑制活性国内外未见报道。